LETTERS FOR ISSUE ON
|
|
- Pearl Phelps
- 5 years ago
- Views:
Transcription
1 S FOR ISSUE ON INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. GLENMARK PHARMACEUTICAL LTD - 2. M/S. BHARAT SERUMS AND VACCINE LTD - CT-NOC 3. M/S PRECISE CHEMIPHARMA PVT LTD - BE-NOC COSMETIC DIVISION S. COMPANY NAME DIARY NO STATUS 1. M/S. HYGIENE FRESH, KERALA APPROVAL 2. M/S. LAMED INDIA, NEW DELHI APPROVAL 3. M/S. AURAINE BOTANICALS PVT LTD., HARYANA APPROVAL 4. M/S. H.H. MARKETING, PUNJAB APPROVAL 5. M/S. AROMATHAI SERVICES PVT LTD., NEW DELHI APPROVAL 6. M/S. NUGA MEDICAL INDIA PVT LTD., NOIDA APPROVAL 7. M/S. VIVA COSMETICS, THANE APPROVAL 8. M/S. COSMETECH HEALTH CARE PRODUCTS, DELHI APPROVAL 9. M/S. BACCAROSE PERFUMES & BEAUTY PRODUCTS PVT LTD., MUMBAI APPROVAL 10. M/S. ARTLIFE WELLNESS PRODUCTS PVT LTD., NEW DELHI APPROVAL 11. M/S. OCEA MARINE COSMETIC PVT LTD., MUMBAI APPROVAL
2 12. M/S. VELLVETTE LIFESTYLE PVT LTD., MUMBAI APPROVAL 13. M/S. INVOGUE COSMETICS, NEW DELHI APPROVAL 14. M/S. BLISS BEAUTY INC., DELHI APPROVAL 15. M/S. NYTEC BEAUTY INTERNATIONAL (PVT) LTD., MUMBAI APPROVAL 16. M/S. GARDENIA COSMOCARE PVT LTD., MUMBAI APPROVAL 17. M/S. SESDERMA PVT LTD., NEW DELHI APPROVAL 18. M/S. L OREAL INDIA PVT LTD., MUMBAI 22075, 22669, 24114, APPROVAL 19. M/S. BELLE VOUS PVT LTD., NEW DELHI APPROVAL REGISTRATION S. NAME OF APPLICANT DIARY TYPE OF 1. PHARMA ACTION HEALTH CARE APPROVAL PVT. LTD 2. FUTURZ-MED APPROVAL 3. TRICHEM APPROVAL 4. P.K. PHARMATECH PVT. LTD APPROVAL 5. IMAGING PRODUCTS INDIA PVT APPROVAL LTD. 6. UNI CHEMIE INTERNATIONAL APPROVAL 7. RUSKIN CHEMIPHARM APPROVAL 8. THE RUSKIN CHEMIPHARM AMENDED RULE-37/SHELF LIFE/MISC S. NAME OF APPLICANT DIARY TYPE OF 1. EISAI PHARMACEUTICAL INDIA APPROVAL PVT. LTD. 2. LUPIN LTD APPROVAL 3. SAI LIFE SCIENCE LTD. NIL IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. UNICHEM LABORATORIES LTD., APPROVAL 2. CIPLA LTD.(GODOWN) APPROVAL
3 3. SKIES APPROVAL 4. AVITECH NUTRITION PVT. LTD APPROVAL 5. AVITECH NUTRITION PVT. LTD APPROVAL 6. AVITECH NUTRITION PVT. LTD APPROVAL 7. AVITECH NUTRITION PVT. LTD APPROVAL 8. AVITECH NUTRITION PVT. LTD APPROVAL 9. AVITECH NUTRITION PVT. LTD APPROVAL 10. ATTIS REMEDIES APPROVAL 11. RENAISSANCE PHARMACEUTICALS APPROVAL 12. LALCHAND BHIMRAJ, APPROVAL 13. ASTRA PHARMACEUTICALS APPROVAL 14. M.K. PHARMA PVT. LTD. C/O. M/S APPROVAL TINI PHARMA PVT. LTD. 15. VITAL THERAPEUTICS AND APPROVAL FORMULATIONS PRIVATE LIMITED 16. DSM SINOCHEM APPROVAL PHARMACEUTICALS INDIA PVT. LTD. 17. JOHNSON & JOHNSON LTD APPROVAL 18. PFIZER LTD APPROVAL LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. BIOMATRIX HEALTHCARE PVT.LTD C/O. M/S. SHREE KRISHNA KESHAV LABORATORIES LTD., AHMEDABAD 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 03 M/S. SHREE KRISHNA KESHAV LABORATORIES LTD, AHMEDABAD 04 M/S. INFUTEC HEALTHCARE LIMITED., PUNJAB ADDITIONAL PRODUCT ADDITIONAL PRODUCT ADDITIONAL PRODUCT APPROVAL VACCINE DIVISION
4 S. COMPANY NAME DY. NO STATUS 1 M/S SANOFI SYNTHELABO INDIA PVT LTD 2 M/S INTAS PHARMACEUTICALS LTD CONTINUATION & CLARIFICATION 28255, APPROVAL & CONTINUATION 3 M/S WOCKHARDT LTD APPROVAL 4 M/S PANAV BIOTECH LTD 30076, 30075, CONTINUATION 5 M/S RELIANCE LIFE SCIENCES PVT, LTD 18796, 30586, APPROVAL & CLARIFICATION 6 M/S HEMOPHILIA FEDERATION APPROVAL GLOBAL CLINICAL TRIAL SR. NAME OF FIRM REFERENCE TYPE OF 1. M/S. J& J TL APPROVAL 2. M/S. MAX NEEMAN 30525/30844/30843/30524 AMENDMENT IN EXPORT NOC /CHANGE IN PI APPROVAL S 3. M/S. KLINERA NEW SITE APPROVAL 4. M/S. QUINTILES CLARIFICATION 5. M/S. NOVARTIS MINUTES OF SEC/TERMINATION 6. M/S. COVANCE CLARIFICATION 7. M/S. SANOFI CLARIFICATION /TL APPROVAL 8. M/S. BMS CHANGE IN SITE ADDRESS APPROVAL 9. M/S. TATA PA APPROVAL
5 MEMORIAL 10. M/S. GEORGE CLINICAL NEW SITES APPROVAL 11. M/S. PFIZER CHANGE IN PI APPROVAL 12. M/S. EXCEL LIFE SCIENCES NEW SITES APPROVAL FDC DIVISION S. NAME OF COMPANY DIARY NO DOCUMENT 1. M/S. SUN PHARMA LABORATORIES SITE ADITION 2. M/S. TORRENT PHARMACEUTICALS CLARIFICATION EXPORT S. NAME OF THE COMPANY REF. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT. LTD., NAVI MUMBAI M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT. LTD., NAVI MUMBAI M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT. LTD., NAVI MUMBAI M/S. ACTIMUS BIOSCIENCES PVT. LTD., VISAKHAPATNAM M/S. AIZANT DRUG RESEARCH SOLUTIONS PVT. LTD., HYDERABAD CLARIFICATION TEST LICENCE TEST LICENCE CLARIFICATION CLARIFICATION
6 6. M/S. AIZANT DRUG RESEARCH SOLUTIONS PVT. LTD., HYDERABAD M/S. AIZANT DRUG RESEARCH SOLUTIONS PVT. LTD., HYDERABAD M/S. ALEMBIC LTD., 9. M/S. ALEMBIC LTD., 10. M/S. ALEMBIC 11. M/S. ALEMBIC 12. M/S. ALEMBIC 13. M/S. ALKEM LABORATORIES LTD., TALOJA , TAL: PANVEL, DIST: RAIGAD 14. M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA LTD., HYDERABAD M/S. APL RESEARCH CENTRE, HYDERABAD M/S. APL RESEARCH CENTRE, HYDERABAD M/S. APOTEX RESEARCH PVT. LTD., BANGALORE M/S. AXIS CLINICAL LTD., HYDERABAD CLARIFICATION APPROVAL CLARIFICATION CLARIFICATION AMENDMENT AMENDMENT APPROVAL APPROVAL AMENDMENT CLARIFICATION CLARIFICATION CLARIFICATION APPROVAL
7 19. M/S. CADILA PHARMACEUTICAL LTD., DHOLKA , AHMEDABAD 20. M/S. CIPLA LIMITED, MUMBAI M/S. CIPLA LIMITED, MUMBAI M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD M/S. EMCURE PHARMACEUTICALS LIMITED, PUNE M/S. EMCURE PUNE M/S. ENEM NOSTRUM REMEDIES PVT. LTD., MUMBAI M/S. GLENMARK NAVI MUMBAI M/S. HETERO LABS LTD., HYDERABAD M/S. LAMBDA THERAPEUTIC RESEARCH LTD., AHMEDABAD M/S. LAMBDA THERAPEUTIC RESEARCH LTD., AHMEDABAD M/S. LAMBDA THERAPEUTIC RESEARCH LTD., AHMEDABAD CLARIFICATION AMENDMENT APPROVAL APPROVAL APPROVAL CLARIFICATION CLARIFICATION CLARIFICATION APPROVAL CLARIFICATION APPROVAL APPROVAL
8 31. M/S. LAMBDA THERAPEUTIC RESEARCH LTD., NAVI MUMBAI M/S. LOTUS LABS PVT. LTD., BANGALORE M/S. LUPIN LIMITED (RESEARCH PARK), PUNE M/S. LUPIN LIMITED (RESEARCH PARK), PUNE M/S. LUPIN LIMITED (RESEARCH PARK), PUNE M/S. LUPIN LIMITED (RESEARCH PARK), PUNE M/S. MACLEODS ANDHERI (EAST), MUMBAI M/S. MYLAN LABORATORIES LIMITED, SECUNDERABAD 39. M/S. STRIDES ARCOLAB LTD., BANGALORE M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA APPROVAL APPROVAL CLARIFICATION CLARIFICATION CLARIFICATION APPROVAL APPROVAL AMENDMENT AMENDMENT CLARIFICATION CLARIFICATION APPROVAL
9 43. M/S. VEEDA CLINICAL RESEARCH PVT. LTD., AHMEDABAD M/S. VEEDA CLINICAL RESEARCH PVT. LTD., AHMEDABAD M/S. WOCKHARDT LIMITED, AURANGABAD M/S. WOCKHARDT LIMITED., MUMBAI M/S. WOCKHARDT LIMITED., MUMBAI APPROVAL APPROVAL APPROVAL CLARIFICATION CLARIFICATION
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 19.06.2015 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT.,
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD
More informationTODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 04.10.2017 MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14608 QUERY 2. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14609 QUERY 3. DR. ULHAS
More informationLETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
More informationLETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 27.12.2017 LVP DIVISION S. NO. COMPANY NAME FTS NO. /Diary No. STATUS 01 M/s. Akums Drugs & Pharmaceuticals, Haridwar 02 M/s. Unique Pharmaceutical Laboratories,Guj. (License No.4)
More informationRESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
More informationFile no./drug Name Name of firm/ Institute Recommendations. New Drugs Division
Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution
More informationPHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
1 Agio Pharmaceuticals Limited 15/31/2013-EP(Engg) dt:21.11.2013 7,98,217.00 2 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt:21.11.2013 15,10,268.00 3 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg)
More informationREGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More informationMinimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33
Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
More informationInformation for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules
Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
More informationEducation. Current Activities
Nirali Mehta, M.Sc., M.Phil. Founder & Consultant Biostatistician Ahmedabad, Gujarat, India. M +91 9377060504 E nirali.mehta@pharma-stats.in W www.pharma-stats.in Education 1998-2001 Bachelor of Science
More informationStatus of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
More informationCompanies Database, Mobile Database, Id Database, Credit
m All India Database We Provides Database Companies Database, Mobile Database, Email Id Database, Credit Card Holder Database, Corporate database, CEO s Database, Corporate Employee Database, Car s Owner
More informationNew Delhi, the 18 th December, 2017 ORDER
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
More informationInformation for Vermont Prescribers of Prescription Drugs Long Form
Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale
More informationORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
More informationList Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)
Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version
More informationA study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY
More informationDataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18
PharmaTrac Overview MAY 18 8434 8956 9655 10422 8112 8917 9549 8258 8921 9406 8668 9630 9381 8662 8373 8999 9013 9796 10413 8742 9315 10050 8458 9180 8601 9092 9767 8364 9145 10583 10173 10387 10217 10476
More informationCase 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
Case 3:15-cv-05982-PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 Liza M. Walsh Christine I. Gannon CONNELL FOLEY LLP One Newark Center 1085 Raymond Boulevard, 19th Floor Newark, New Jersey
More informationStatus of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015 S. No. Firm Name of Formulation Registration Certificate No. & Validity 1. M/s. Nirlac Chemicals,14 th
More informationTOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.
Number of Companies consisting of Market Share of 1% & Above 2 3.1 Adrenaline Injection 1 mg/ml Per ml Sum of MAT value considered for price calculation (in Lakhs) 152.69 Sum of PTR per unit considered
More informationPHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
Disbursement of MDA Claims to Individual Exporters during (-11) 1 JPN Pharma API China 80,000.00 2 Unique Biotech Limited Bio May 3-6, 80,000.00 3 Titan Biotech Limited Cphi Japan 21st to 23rd April 80,000.00
More informationRecommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division
Recommetions of thesec (Dermatology & Allergy) made in its 23 rd meeting held on 11.05.2017 at CDSCO HQ New Delhi: File /Drug Name Recommetions New Drugs Division 1 12-28/15-DC (Pt-B) Apremilast 10/20/30
More information1. Dr. Shyam Agarwal, Joint Secretary, Department of Commerce. 2. Shri A.K. Bamba, Director, Department of Commerce
Minutes of Meeting of Inter Ministerial Committee (IMC) for consideration of proposals for setting up ICDs / CFSs held under Chairmanship of Shri P.K. Chaudhery, Additional Secretary (AS), Department of
More informationSubject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application
More informationWHO PUBLIC INSPECTION REPORT (WHOPIR) Contract Research Organization
SOP 408.4 Annex C 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int Part 1: General information WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the
More information10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE
10 th SEC- (Reproductive & Urology)meetingheld on 16-01-2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 PROGRAMME SCHEDULE Recommendation:- The 10 th SEC (Reproductive and Urology) meeting
More informationCase 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023
Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,
More informationTRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF SPTEMBER-2013 DATE OF HEARING 10.09.2013 R. T. M. 1. 842945/16 Rect. AMD-249059 Mr. Pankajbhai Sitaram Nayak, Hearing on Section
More information3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.
MINUTES OF THE 6 th MEETING OF TECHNICAL COMMITTEE HELD ON 25-07-2013 UNDER CHAIRMANSHIP OF DGHS FOR SUPERVISING CLINICAL TRIALS ON NEW CHEMICAL ENTITIES IN THE LIGHT OF DIRECTIONS OF THE HON BLE SUPREME
More informationSupplier/ Manufacturer(s) Unit III, Survey No 51, Plot No IDA, Jeedimetla, Hyderabad, Telangana, Hetero labs limited
LIST OF DELISTED PRODUCTS Not eligible for procurement with the Global Fund resources 06th of April 2018 Delisted Mar-18 Ritonavir (RTV) 0 mg Tablet Unit Survey No 51, Plot No 22-1 IDA, Jeedimetla, Hyderabad,
More informationCase 2:09-cv DMC-CCC Document 1 Filed 03/20/2009 Page 1 of 95. Of Counsel:
Case 2:09-cv-01302-DMC-CCC Document 1 Filed 03/20/2009 Page 1 of 95 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza Newark, NJ 07102 (973) 286-6700 clizza@saul.com Attorneys for Plaintiff
More informationAmeya works predominantly in the architectural design, interiors and project management segments in healthcare industry
Introduction Ameya design is premier health care consultancy firm with experience with design and execution of largest number of private sector health care facility in India. Key Information Ameya works
More informationStatus of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016 RECOMBINANT PRODUCTS S. No. Firm Name of Formulation Import License No. &
More informationInformation for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets)
Information for Vermont Prescribers of Prescription Drugs Lunesta (eszopiclone tablets) This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety.
More informationINDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION ROUND-2
G B Pant Hospital J L Nehru Marg, Delhi Cardiac Anaesthesia 1 Delhi-110002 Indraprastha s Delhi Cardiac Anaesthesia 1 Medanta- The Medicity Sector-38, Gurgaon, Haryana Cardiac Anaesthesia 5 Haryana-122001
More informationDoing Business in India; Nutritional ingredients supplier perspective. Jaime Piza DSM Nutritional Products November, 2012
Doing Business in India; Nutritional ingredients supplier perspective Jaime Piza DSM Nutritional Products November, 2012 Table of contents Doing business IFC classification. Still some hurdle to take...
More informationM/s. Hetero Labs Ltd.
:- The 1 st SEC (Gastroenterology&Hepatology) meeting deliberated the proposals on 06.01.2017 and recommended the following:- Agenda New Drugs Division Proposal 1 12-54/16-DC Sofosbuvir and Velpatasvir
More informationName of firm/applicant. Torrent Pharmaceuticals. Glenmark Pharmaceuticals. M/s. Torrent Pharmaceutical. Torrent Pharmaceuticals
Recommendation:- The 14 Th SEC (Cardiovascular & Renal) deliberated the proposals on 21.08.2014 and recommended the following:- Agenda no. File no Name of firm/applicant Recommendations 1. 04-228/06-D(pt
More informationORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
More informationCHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
More informationInformation for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets
Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets The prices listed below are Average Wholesale Prices ( AWP ) as established and made available to the public
More informationTRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF JUNE-2016 DATE OF HEARING 13.06.2016 1. 934855/05 Opp. AMD-245342 M/s. Ajanta Pharma Limited, Mumbai / Mr. Manoj G. Menda, Mumbai
More informationRecommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on 05.11.2014 and recommended the following:- Agend a No. File No. 1. File No.: 12-75/13-DC Afatinib film coated tablet
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 07 Oct 2018 22:54:26 GMT) CTRI Number Last Modified On 11/05/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationBRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
More informationName of firm/applicant
Recommendation:- The 18 th Subject Expert Committee (Oncology & Hematology) deliberated the proposals on 04.07.2014 and recommended the following:- Agenda no. Drug name Name of firm/applicant Recommendations
More informationFree Trial Future Generics Database
API Atazanavir Structure O 2 C N H O H N OH N NH O N H N CO2 Brand REYATAZ (BMS : World) Indication Antiviral Originator Ciba-Geigy (Novartis) Developer / Licensee BMS Comments Atazanavir is an azapeptide
More informationMedicines availability short-term supply issues Last updated 01/05/18
Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is
More informationForm IV-A Short-term Inter-State Transactions of Electricity by Trading Licensees ( RTC*)
Form IV-A Short-term Inter- Transactions of Electricity by Trading Licensees ( RTC*) Trading Licensee: Tata Power Trading Co. Ltd. Period of Power Delivery Start date (DD/MM/YYYY) End date (DD/MM/YYYY)
More informationRecommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml
: I approve the minutes of 32 nd SEC (Antimicrobial, Antiviral, Antiparasitic and Antifungal) held on 11.04.2017 at CDSCO HQ New Delhi and recommended the following: Agend New Drugs Division 1 12-34/12-DC
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 02 Sep 2018 23:38:24 GMT) CTRI Number Last Modified On 05/02/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationSolvay in India January, 2014
Solvay in India January, 2014 SOLVAY in India, Innovation and Operational excellence Jodhpur Hichem (JV) Ahmedabad Hichem (JV) Bhiwani Hichem (JV) Delhi Hichem (JV) Solvay R&D center Vadodara Panoli Solvay
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 07 Oct 2018 14:20:17 GMT) CTRI Number Last Modified On 13/02/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More information### About Bharat Biotech
Press Release Bharat Biotech Bharat Biotech Launches Typbar-TCV, world s first clinically proven typhoid conjugate vaccine for infants 6 months & older and Adults The new vaccine brings hope to millions
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same
More informationMs channel weight chart
Ms channel weight chart SS303, SS304, 304L, 308, 309, 309L, 310, 316, 316L, 321. MAHAVIR STEEL INDUSTRIES developes specific sections. Specific sizes in any section can be developed for economical and
More information+91-8048762617 Innovexia Life Sciences Private Limited http://www.innovexia.in/ We are a renowned organization, which is engaged in manufacturing, supplying, trading and wholesaling a wide range of Pharmaceutical
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 24 Nov 2018 11:16:02 GMT) CTRI Number CTRI/2010/091/000422 [Registered on: 05/08/2010] - Last Modified On 01/03/2013 Post Graduate Thesis Type of Trial
More informationAvailable online at Universal Research Publications. All rights reserved. Original Article
Available online at http://www.urpjournals.com International Journal of Analytical and Bioanalytical chemistry Universal Research Publications. All rights reserved Original Article Application of HPTLC
More informationORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New
More informationInformation for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same
More informationEdmund Healthcare Pvt. Ltd.
+91-8048410921 Edmund Healthcare Pvt. Ltd. https://www.edmundhealthcare.in/ Our firm is ranked as the leading Trader and Supplier of a wide array of Pharmaceutical Injection, Pharmaceutical Tablets, Pharmaceutical
More informationWhat s New
What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related
More informationInformation for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable
More informationINDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2015 ADMISSION SESSION
Jubilee Hills, Hyderabad-34 Critical Care Medicine 3 Jubilee Hills, Hyderabad-34 Interventional Cardiology 1 Jubilee Hills, Hyderabad-34 Pediatric Cardiology 1 Care Hospital Road No. 1, Banjara Hills,
More informationBOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS
BOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS BIO022G August 2015 Kim Lawson Project Analyst ISBN: 1-62296-134-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationAGENDA PAPERS FOR THE EIGHTEENTH MEETING SUB-COMMITTEE ON LARGE ANIMALS (SCLA)
AGENDA PAPERS FOR THE EIGHTEENTH MEETING OF SUB-COMMITTEE ON LARGE ANIMALS (SCLA) DATE : 18.04.2005 TIME : 3 : 00 P.M. VENUE : 8 TH FLOOR, JEEVAN PRAKASH BUILDING, 25, KASTURBA GANDHI MARG, NEW DELHI.
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS
More informationHyderabad, India Delegates. April 27, Tentative program A comprehensive Bioanalysis conclave. Key notes.
INTERNATIONAL CONFERENCE &EXHIBITION Tentative program A comprehensive Bioanalysis conclave 7+ Key notes 50+ Poster presentations 100+ Delegates 2 + Panel Discussions April 27, 2018 Hyderabad, India Invitation
More informationStatus of Registration Certificate (Form 41) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015
Status of Registration Certificate (Form 41) of Human Vaccines, Recombinant Products and Veterinary Vaccine issued from 01/01/2015 to 27/02/2015 S. No. Firm Name of Formulation Registration Certificate
More informationDate: November 28, 2010 Edition: Bangalore. The Times of India
Date: November 28, 2010 Edition: Bangalore The Times of India Date: November 28, 2010 Edition: Bangalore The New Indian Express Date: November 28, 2010 Edition: Bangalore DNA Date: November 29, 2010 Edition:
More informationRecent trends and challenges
INTERNATIONAL CONFERENCE ON Recent trends and challenges in Bioanalysis Tentative Program Bioanalytica-2017 Hyderabad,India JUNE 30, 2017 Invitation ABC Biologics welcomes you to attend the international
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 11 Jan 2019 05:36:45 GMT) CTRI Number Last Modified On 30/03/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationhttps://www.indiamart.com/max-pharma/
+91-8048603315 Max Pharma https://www.indiamart.com/max-pharma/ We are one of the leading organizations engaged in manufacturing and supplying a wide range of Pharmaceutical Drugs. These include Tablets,
More informationFROST & SULLIVAN. Publications Division - Terms and Conditions of Business
FROST & SULLIVAN Publications Division - Terms and Conditions of Business 1. Frost & Sullivan and FICCI takes no responsibility for any incorrect information supplied by manufacturers or users. Quantitative
More informationMEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS. PHM154A September Anand Gijare Project Analyst ISBN:
MEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS PHM154A September 2013 Anand Gijare Project Analyst ISBN: 1-56965-544-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationVarna Suraksha LXi12. Features of the System: Master Console. Specifications:
Varna Suraksha LXi12 Varna Suraksha Rodent Repellers - LXi12 Master Consoles are high frequency signal generators. These signals are fed to the transducers which in turn convert them into high frequency
More informationA regional epidemiology of India s NCD s risk factors focusing particularly on Maharashtra: A call for Health promotion once again
Original Article A regional epidemiology of India s NCD s risk factors focusing particularly on : A call for Health promotion once again Abstract Balu Natha Mote Center of Public Health, Masters of Public
More informationGlobal Nutraceuticals Market
Published on NOVONOUS (https://www.novonous.com) Home > Global Nutraceuticals Market 2016-2020 Global Nutraceuticals Market 2016-2020 Publication ID: NOV1016004 Publication Date: October 14, 2016 Pages:
More informationReverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms
Asian Journal of Chemistry Vol. 21, No. 2 (2009), 829-833 Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms B.V.V.S. JAGADEESH, S. SATYANARAYANA RAJU, V.JAYATHIRTHA RAO and J.V.L.N.
More information